Finnrick - Ensuring a Safer and More Transparent Supply Chain
Royal Peptides

Royal Peptides
Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP antagonist) from Royal Peptides between 16 Mar 2025 and 25 Mar 2025. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
C
OKAY
Royal Peptides
Tirzepatide
Tested 6 Samples
Last test 25 Mar 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Royal Peptides

Samples are tested in commercial labs

Tests Count

6

Scores

AVG5.4MIN4.2MAX6.5

Last

25 Mar 2025

First

16 Mar 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
25 Mar 2025View6.410mg10.934mg+9.3%99.80%(no batch ID)No Label / Silver Crimp / Clear Green CapLab CFinnrick
25 Mar 2025View6.510mg11.005mg+10.1%99.89%(no batch ID)No Label / Silver Crimp / Clear Green CapLab CFinnrick
25 Mar 2025View4.810mg12.630mg+26.3%99.86%(no batch ID)No Label / Silver Crimp / Clear Green CapLab CFinnrick
16 Mar 2025View5.310mg11.130mg+11.3%99.56%(no batch ID)No Label / Silver Crimp / Clear Green CapLab AFinnrick
16 Mar 2025View5.110mg11.010mg+10.1%99.33%(no batch ID)No Label / Silver Crimp / Clear Green CapLab AFinnrick
16 Mar 2025View4.210mg11.140mg+11.4%99.04%(no batch ID)No Label / Silver Crimp / Clear Green CapLab AFinnrick